Tuberculosis other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Mashal Awais (talk | contribs) |
Mohamed riad (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Apart from [[X-rays]], [[Computed tomography|CT scans]], [[MRI]], [[diagnostic studies]] that can be done in patients with [[tuberculosis]] are the Xpert MTB/RIF test, Adenosine Deaminase Test, and [[Nucleic Acid Amplification Test]] ([[Nucleic acid test|NAAT]]). | |||
<br /> | <br /> | ||
| Line 11: | Line 11: | ||
====Xpert MTB/RIF Test==== | ====Xpert MTB/RIF Test==== | ||
*The Xpert MTB/RIF test is a molecular test that | *The [[Xpert MTB/RIF]] test is a [[molecular]] [[test]] that is used to detect the [[DNA]] of the tubercule bacillus complex (MTBC) and also the [[genetic mutations]] related to [[Drug resistance|resistance]] to [[rifampin]] in unprocessed [[sputum]] and concentrated [[sputum]] [[sediments]] <ref> {{cite web |url=http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6241a1.htm | title=Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — the United States, 2013}}</ref> | ||
*WHO recommends the Xpert MTB/RIF test for the initial diagnosis of MDR-TB or HIV | *[[World Health Organization]] ([[World Health Organization|WHO]]) recommends the Xpert MTB/RIF test for the initial diagnosis of [[multi-drug resistance TB]] ([[Multi-drug-resistant tuberculosis|MDR]]-TB) or [[Human Immunodeficiency Virus (HIV)|HIV]] co-infection.<ref name="WHO XPERT"> {{cite web| url=http://who.int/tb/features_archive/factsheet_xpert.pdf| title=WHO Tuberculosis Diagnosis Xpert MTB/RIF Test 2013}} </ref> | ||
*The advantages of this rapid Tuberculosis test are the following:<ref name="WHO XPERT"> {{cite web| url=http://who.int/tb/features_archive/factsheet_xpert.pdf| title=WHO Tuberculosis Diagnosis Xpert MTB/RIF Test 2013}} </ref> | *The advantages of this rapid Tuberculosis test are the following:<ref name="WHO XPERT"> {{cite web| url=http://who.int/tb/features_archive/factsheet_xpert.pdf| title=WHO Tuberculosis Diagnosis Xpert MTB/RIF Test 2013}} </ref> | ||
| Line 21: | Line 21: | ||
====Adenosine Deaminase==== | ====Adenosine Deaminase==== | ||
It is | It is an additional test in case of suspecting [[Tuberculosis|TB]] in a patient.<ref name="pmid24319523">{{cite journal| author=Farazi A, Moharamkhani A, Sofian M| title=Validity of serum adenosine deaminase in diagnosis of tuberculosis. | journal=Pan Afr Med J | year= 2013 | volume= 15 | issue= | pages= 133 | pmid=24319523 | doi=10.11604/pamj.2013.15.133.2100 | pmc=PMC3852508 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24319523 }} </ref> | ||
*ADA is used for | *[[ADA]] is used for [[Tuberculosis|TB]] [[diagnosis]] in endemic regions where [[Tuberculosis|TB]] diagnostic tools are not affordable. | ||
* | *[[Isoenzymes]] are more accurate. | ||
*ADA has a high degree of [[Sensitivity (tests)|sensitivity]] for [[Tuberculous meningitis|TB meningitis]] and [[Pleural disease|pleural]] [[Tuberculosis|TB]] . | |||
====Nucleic Acid Amplification Tests (NAAT) <small><small><small> Adapted from CDC <ref name="CDC NAAT"> {{Cite web| url=http://www.cdc.gov/tb/publications/guidelines/amplification_tests/reccomendations.htm| title= CDC Report of an Expert Consultation on the Uses of Nucleic Acid Amplification Tests for the Diagnosis of Tuberculosis}}</ref></small></small></small>==== | ====Nucleic Acid Amplification Tests (NAAT) <small><small><small> Adapted from CDC <ref name="CDC NAAT"> {{Cite web| url=http://www.cdc.gov/tb/publications/guidelines/amplification_tests/reccomendations.htm| title= CDC Report of an Expert Consultation on the Uses of Nucleic Acid Amplification Tests for the Diagnosis of Tuberculosis}}</ref></small></small></small>==== | ||
* | *[[NAAT]] is a group of tests that use [[polymerase chain reaction (PCR)]] to detect a [[Mycobacterium|mycobacterial]] macromolecule. | ||
*These tests | *These tests are variable regarding the accuracy and which [[macromolecule]] sequence they can detect. | ||
*The two | *The two most widely available tests are the amplified tubercle bacillus direct test (MTD, Gen-Probe) and Amplicor (Roche Diagnostics). | ||
*The CDC recommends that [[NAA testing]] should be performed on a respiratory specimen from each patient with signs and symptoms of active pulmonary TB disease for whom a diagnosis of TB is | *The [[Centers for Disease Control and Prevention|CDC]] recommends that [[NAA testing]] should be performed on a respiratory specimen from each patient with signs and symptoms of active pulmonary TB disease for whom a diagnosis of [[Tuberculosis|TB]] is suspected, but has not been confirmed. | ||
*[[NAA testing]] | *[[NAA testing]] cannot replace the value for [[AFB stain|AFB]] [[Smear test|smear]] and [[Culture medium|culture]]. | ||
*A single positive NAA test result can support the diagnosis of TB during a patient for whom there's an inexpensive index of suspicion. This result should trigger reporting to public health officials, initiation of treatment if not already started, and vigorous efforts to get an isolate for drug susceptibility testing. | *A single positive [[Nucleic acid test|NAA]] test result can support the [[diagnosis]] of [[Tuberculosis|TB]] during a patient for whom there's an inexpensive index of suspicion. This result should trigger reporting to public health officials, initiation of treatment if not already started, and vigorous efforts to get an isolate for [[drug susceptibility testing]]. | ||
*In a patient with little suspicion of getting active TB, one positive NAA test result should be viewed with suspicion (i.e., a possible false-positive result) and interpreted within the same way as one [[culture-positive]] result, i.e., by correlating the results with other diagnostic findings. | *In a patient with little suspicion of getting active TB, one positive [[Nucleic acid test|NAA]] test result should be viewed with suspicion (i.e., a possible [[False-positive test result|false-positive]] result) and interpreted within the same way as one [[culture-positive]] result, i.e., by correlating the results with other diagnostic findings. | ||
*A single negative NAA test result should never be used as a specific test to exclude TB, especially in suspects with a moderate to high clinical suspicion of TB. | *A single negative [[NAAT|NAA]] test result should never be used as a specific test to exclude [[Tuberculosis|TB]], especially in suspects with a moderate to high clinical suspicion of [[Tuberculosis|TB]]. However, the negative [[NAAT]] result may be used as additional information to help with making clinical decisions to establish a [[work-up]] for an alternate [[diagnosis]] or to prevent unnecessary use of [[Tuberculosis|TB]] [[medication]] in suspected [[cases]]. | ||
*The [[FDA-approved]] NAAT tests for TB have slightly less sensitivity than [[culture-isolation methods]], and therefore the 15% -20% of U.S. TB cases that are reported with negative culture results can also have negative NAA test results. Thus, a negative NAA test result doesn't exclude the diagnosis of TB. | *The [[FDA-approved]] [[NAAT]] tests for [[Tuberculosis|TB]] have slightly less [[Sensitivity (tests)|sensitivity]] than [[culture-isolation methods]], and therefore the 15% -20% of U.S. [[Tuberculosis|TB]] cases that are reported with negative culture results can also have negative [[NAAT|NAA]] test results. Thus, a negative [[Nucleic acid test|NAA]] test result doesn't exclude the [[diagnosis]] of [[Tuberculosis|TB]]. | ||
*Further research is required before specific recommendations are often made on the utilization of NAAT testing within the diagnosis of TB in children who cannot produce [[sputum]] and within the diagnosis of [[extrapulmonary]] TB, although there's much scientific evidence of the utility of such testing in individual cases. | *Further research is required before specific recommendations are often made on the utilization of [[NAAT]] testing within the [[diagnosis]] of [[Tuberculosis|TB]] in children who cannot produce [[sputum]] and within the [[diagnosis]] of [[extrapulmonary]] [[Tuberculosis|TB]], although there's much scientific evidence of the utility of such testing in individual cases. | ||
==References== | ==References== | ||
Latest revision as of 01:46, 27 March 2021
|
Tuberculosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tuberculosis other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Tuberculosis other diagnostic studies |
|
Risk calculators and risk factors for Tuberculosis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mashal Awais, M.D.[2]; Alejandro Lemor, M.D. [3]
Overview
Apart from X-rays, CT scans, MRI, diagnostic studies that can be done in patients with tuberculosis are the Xpert MTB/RIF test, Adenosine Deaminase Test, and Nucleic Acid Amplification Test (NAAT).
Other Diagnostic Studies
Xpert MTB/RIF Test
- The Xpert MTB/RIF test is a molecular test that is used to detect the DNA of the tubercule bacillus complex (MTBC) and also the genetic mutations related to resistance to rifampin in unprocessed sputum and concentrated sputum sediments [1]
- World Health Organization (WHO) recommends the Xpert MTB/RIF test for the initial diagnosis of multi-drug resistance TB (MDR-TB) or HIV co-infection.[2]
- The advantages of this rapid Tuberculosis test are the following:[2]
- Detects M. tuberculosis and rifampicin drug resistance simultaneously.
- Results are available in less than 2 hours so the patient can be treated the same day of the test.
- The bio-safety requirements and training are minimal.
- It can be stored in non-conventional laboratories.
Adenosine Deaminase
It is an additional test in case of suspecting TB in a patient.[3]
- ADA is used for TB diagnosis in endemic regions where TB diagnostic tools are not affordable.
- Isoenzymes are more accurate.
- ADA has a high degree of sensitivity for TB meningitis and pleural TB .
Nucleic Acid Amplification Tests (NAAT) Adapted from CDC [4]
- NAAT is a group of tests that use polymerase chain reaction (PCR) to detect a mycobacterial macromolecule.
- These tests are variable regarding the accuracy and which macromolecule sequence they can detect.
- The two most widely available tests are the amplified tubercle bacillus direct test (MTD, Gen-Probe) and Amplicor (Roche Diagnostics).
- The CDC recommends that NAA testing should be performed on a respiratory specimen from each patient with signs and symptoms of active pulmonary TB disease for whom a diagnosis of TB is suspected, but has not been confirmed.
- NAA testing cannot replace the value for AFB smear and culture.
- A single positive NAA test result can support the diagnosis of TB during a patient for whom there's an inexpensive index of suspicion. This result should trigger reporting to public health officials, initiation of treatment if not already started, and vigorous efforts to get an isolate for drug susceptibility testing.
- In a patient with little suspicion of getting active TB, one positive NAA test result should be viewed with suspicion (i.e., a possible false-positive result) and interpreted within the same way as one culture-positive result, i.e., by correlating the results with other diagnostic findings.
- A single negative NAA test result should never be used as a specific test to exclude TB, especially in suspects with a moderate to high clinical suspicion of TB. However, the negative NAAT result may be used as additional information to help with making clinical decisions to establish a work-up for an alternate diagnosis or to prevent unnecessary use of TB medication in suspected cases.
- The FDA-approved NAAT tests for TB have slightly less sensitivity than culture-isolation methods, and therefore the 15% -20% of U.S. TB cases that are reported with negative culture results can also have negative NAA test results. Thus, a negative NAA test result doesn't exclude the diagnosis of TB.
- Further research is required before specific recommendations are often made on the utilization of NAAT testing within the diagnosis of TB in children who cannot produce sputum and within the diagnosis of extrapulmonary TB, although there's much scientific evidence of the utility of such testing in individual cases.
References
- ↑ "Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — the United States, 2013".
- ↑ 2.0 2.1 "WHO Tuberculosis Diagnosis Xpert MTB/RIF Test 2013" (PDF).
- ↑ Farazi A, Moharamkhani A, Sofian M (2013). "Validity of serum adenosine deaminase in diagnosis of tuberculosis". Pan Afr Med J. 15: 133. doi:10.11604/pamj.2013.15.133.2100. PMC 3852508. PMID 24319523.
- ↑ "CDC Report of an Expert Consultation on the Uses of Nucleic Acid Amplification Tests for the Diagnosis of Tuberculosis".